Binding of α-synuclein oligomers to Cx32 facilitates protein uptake and transfer in neurons and oligodendrocytes
Autor: | Jürgen Winkler, Martin Hallbeck, Martin Ingelsson, Per Svenningsson, Christopher Sackmann, Alana Hoffmann, Juan F. Reyes |
---|---|
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Gap Junction Proteins Multiple system atrophy (MSA) animal diseases Alzheimer’s disease (AD) Connexins Cx32 Mice 0302 clinical medicine Protein uptake heterocyclic compounds Prion-like transfer Neurons Chemistry Brain GJB1 Parkinson Disease Parkinson’s disease (PD) Cell biology Oligodendroglia Alzheimer's disease (AD) alpha-Synuclein Parkinsons disease (PD) Alzheimers disease (AD) Cell-to-cell transfer Gap junction proteins alpha-Synuclein (-syn) Neurovetenskaper Intracellular Parkinson's disease (PD) Pathology and Forensic Medicine 03 medical and health sciences Cellular and Molecular Neuroscience Atrophy stomatognathic system mental disorders medicine Animals Original Paper urogenital system alpha-Synuclein (α-syn) Neurosciences Multiple System Atrophy medicine.disease nervous system diseases 030104 developmental biology nervous system α synuclein Neurology (clinical) 030217 neurology & neurosurgery |
Zdroj: | Acta Neuropathologica |
ISSN: | 1432-0533 0001-6322 |
Popis: | The intercellular transfer of alpha-synuclein (α-syn) has been implicated in the progression of Parkinson’s disease (PD) and multiple system atrophy (MSA). The cellular mechanisms underlying this process are now beginning to be elucidated. In this study, we demonstrate that the gap junction protein connexin-32 (Cx32) is centrally involved in the preferential uptake of α-syn oligomeric assemblies (oα-syn) in neurons and oligodendrocytes. In vitro, we demonstrate a clear correlation between Cx32 expression and oα-syn uptake. Pharmacological and genetic strategies targeting Cx32 successfully blocked oα-syn uptake. In cellular and transgenic mice modeling PD and MSA, we observed significant upregulation of Cx32 which correlates with α-syn accumulation. Notably, we could also demonstrate a direct interaction between α-syn and Cx32 in two out of four human PD cases that was absent in all four age-matched controls. These data are suggestive of a link between Cx32 and PD pathophysiology. Collectively, our results provide compelling evidence for Cx32 as a novel target for therapeutic intervention in PD and related α-synucleinopathies. Electronic supplementary material The online version of this article (10.1007/s00401-019-02007-x) contains supplementary material, which is available to authorized users. |
Databáze: | OpenAIRE |
Externí odkaz: |